rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2001-3-30
|
pubmed:abstractText |
The aim of the study was to analyze the benefit/toxicity profile of a second-line treatment with carboplatin alone or carboplatin plus another non-cross-resistant drug (epidoxorubicin) in ovarian cancer patients sensitive to cisplatin-based chemotherapy at first-line treatment.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0090-8258
|
pubmed:author |
pubmed-author:Associazione per la Ricerca in Ginecologia Oncologia (ARGO 96) Study...,
pubmed-author:BolinJJ,
pubmed-author:FranchiMM,
pubmed-author:GiardinaGG,
pubmed-author:MangiliGG,
pubmed-author:MelpignanoMM,
pubmed-author:ParazziniFF,
pubmed-author:PrestiMM,
pubmed-author:ScarfoneGG,
pubmed-author:TateoSS,
pubmed-author:VillaAA
|
pubmed:copyrightInfo |
Copyright 2001 Academic Press.
|
pubmed:issnType |
Print
|
pubmed:volume |
81
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11277642-Adult,
pubmed-meshheading:11277642-Aged,
pubmed-meshheading:11277642-Antineoplastic Agents,
pubmed-meshheading:11277642-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11277642-Carboplatin,
pubmed-meshheading:11277642-Disease-Free Survival,
pubmed-meshheading:11277642-Drug Administration Schedule,
pubmed-meshheading:11277642-Epirubicin,
pubmed-meshheading:11277642-Epithelium,
pubmed-meshheading:11277642-Female,
pubmed-meshheading:11277642-Humans,
pubmed-meshheading:11277642-Middle Aged,
pubmed-meshheading:11277642-Neoplasm Staging,
pubmed-meshheading:11277642-Ovarian Neoplasms
|
pubmed:year |
2001
|
pubmed:articleTitle |
Carboplatin alone vs carboplatin plus epidoxorubicin as second-line therapy for cisplatin- or carboplatin-sensitive ovarian cancer.
|
pubmed:affiliation |
I(a) Clinica Ostetrico Ginecologica, Università di Milano, Milan, Italy.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|